Modified Titanium Implant as a Gateway to the Human Body : The Implant Mediated Drug Delivery System

Abstract EN

The aim of this study was to investigate the efficacy of a proposed new implant mediated drug delivery system (IMDDS) in rabbits.

The drug delivery system is applied through a modified titanium implant that is configured to be implanted into bone.

The implant is hollow and has multiple microholes that can continuously deliver therapeutic agents into the systematic body.

To examine the efficacy and feasibility of the IMDDS, we investigated the pharmacokinetic behavior of dexamethasone in plasma after a single dose was delivered via the modified implant placed in the rabbit tibia.

After measuring the plasma concentration, the areas under the curve showed that the IMDDS provided a sustained release for a relatively long period.

The result suggests that the IMDDS can deliver a sustained release of certain drug components with a high bioavailability.

Accordingly, the IMDDS may provide the basis for a novel approach to treating patients with chronic diseases.